Quantbot Technologies’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Quantbot Technologies’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-36,619	Closed	-$270K	–	1482
2016 Q2	$270K	Buy	36,619 +27,719	+311%	+$208K	0.03%	517
2016 Q1	$56K	Sell	8,900 -39,258	-82%	-$220K	0.01%	852
2015 Q4	$300K	Buy	48,158 +17,985	+60%	+$118K	0.05%	362
2015 Q3	$176K	Buy	30,173 +23,569	+357%	+$182K	0.03%	567
2015 Q2	$54K	Sell	6,604 -1,030	-13%	-$9.11K	0.01%	802
2015 Q1	$62K	Buy	+7,634	New	+$56.4K	0.02%	735
2014 Q4	–	Sell	-37,896	Closed	-$204K	–	1562
2014 Q3	$204K	Sell	37,896 -14	-0%	-$82	0.03%	693
2014 Q2	$241K	Buy	+37,910	New	+$261K	0.04%	509

Other funds holding ARIA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Quantbot Technologies's ARIA Position: Q3 2016 in Review

Quantbot Technologies sold out of Ariad Pharmaceuticals Inc (ARIA) in Q3 2016, closing a stake of 36,619 shares — an estimated $270K sold.

Quantbot Technologies first reported a position in ARIA in Q2 2014 and held it in 8 quarters. The position peaked at $300K in Q4 2015. 202 funds tracked by Wall St. Rank hold ARIA as of Q3 2016.

Quantbot Technologies reported no remaining Ariad Pharmaceuticals Inc position as of Q3 2016 after selling out during the quarter.
Quantbot Technologies sold 36,619 Ariad Pharmaceuticals Inc shares in Q3 2016, an estimated $270K.
Quantbot Technologies first reported a position in Ariad Pharmaceuticals Inc in Q2 2014 and held it in 8 quarters.
Quantbot Technologies's Ariad Pharmaceuticals Inc position peaked at $300K in Q4 2015.
202 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q3 2016.

Based on Quantbot Technologies's 13F filing for Q3 2016, filed 31 Oct 2016.